Valuation — not yet established
No valuation for PMV Pharma is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($131.9M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·Watchlist + deal alerts for PMV Pharma
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2020 | Later Stage VC (Series D) | $70.0M | ▮ | ▮ |
| Nov 2019 | Later Stage VC (Series C) | $61.9M | ▮ | ▮ |
How PMV Pharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For PMV Pharma, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has PMV Pharma raised?
- PMV Pharma has raised $131.9M in total funding across 2 recorded rounds.
- When did PMV Pharma last raise?
- PMV Pharma last raised in Jul 2020 (Later Stage VC (Series D)), raising $70.0M.